Skip to main content
HR 1391 110th Congress House International Affairs AIDS (Disease) Child health Commerce Communicable diseases Competition Congress Congressional reporting requirements Developing countries Development credit institutions Drug approvals Drug industry Epidemics Families Foreign Trade and International Finance Foreign investments Government Operations and Politics Health Health planning Human immunodeficiency viruses

Vaccines for the Future Act of 2007

Introduced: March 7, 2007 See on congress.gov
This bill died when the 110th Congress ended
It never became law before the 110th Congress (2007–2008) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 13, 2007
Referred to the Subcommittee on Domestic and International Monetary Policy, Trade, and Technology.
Mar 8, 2007
Referred to the Subcommittee on Health.
Mar 7, 2007
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Foreign Affairs, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 7, 2007
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Vaccines for the Future Act of 2007- Directs the President to establish a strategy to accelerate efforts to develop vaccines and microbicides for neglected diseases such as HIV/AIDS, malaria, and tuberculosis, which shall: (1) expand public-private partnerships; (2) create economic incentives for such vaccines' research, development, and manufacturing; (3) include the negotiation of advanced market commitments; (4) address related intellectual property and regulatory approval issues; (5) maximize U.S. capabilities to support clinical trials in developing countries; (6) expand the purchase and delivery of existing vaccines; and (7) address the challenges of advance delivery of vaccines in developing countries.

Directs the Secretary of the Treasury to enter into negotiations with the World Bank, the International Development Association, Global Alliance for Vaccines and Immunizations, and other interested parties to establish advanced market commitments to purchase such vaccines and microbicides.

What's happening now April 13, 2007

Referred to the Subcommittee on Domestic and International Monetary Policy, Trade, and Technology.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 5
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1391: Vaccines for the Future Act of 2007. 110th Congress. Open America. https://openamerica.io/bill/110-HR-1391/
MLA
"H.R. 1391: Vaccines for the Future Act of 2007." 110th Congress, 2026, Open America, https://openamerica.io/bill/110-HR-1391/.
Bluebook (legal)
H.R. 1391, 110th Cong. (2026), https://openamerica.io/bill/110-HR-1391/.
Markdown link
[H.R. 1391: Vaccines for the Future Act of 2007](https://openamerica.io/bill/110-HR-1391/)
Report a problem